牛牛AI助理已提取核心訊息
Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of February 2024. The report details the proceedings of an extraordinary general meeting (EGM) held on January 30, 2024, Beijing Time, which corresponds to January 29, 2024, Eastern Time. During the EGM, shareholders representing approximately 79.65% of Jin Medical's total outstanding ordinary shares voted on a proposal to subdivide each existing ordinary share into twenty shares, effectively reducing the par value from US$0.001 to US$0.00005 each. The subdivision is set to take effect by March 31, 2024, as determined by the company's directors. The proposal was overwhelmingly approved with 6,234,204 votes in favor, 118 against, and no abstentions. This move will increase the authorized share capital to 1,000,000,000 shares at the new par value, aligning with the company's growth strategy.
Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of February 2024. The report details the proceedings of an extraordinary general meeting (EGM) held on January 30, 2024, Beijing Time, which corresponds to January 29, 2024, Eastern Time. During the EGM, shareholders representing approximately 79.65% of Jin Medical's total outstanding ordinary shares voted on a proposal to subdivide each existing ordinary share into twenty shares, effectively reducing the par value from US$0.001 to US$0.00005 each. The subdivision is set to take effect by March 31, 2024, as determined by the company's directors. The proposal was overwhelmingly approved with 6,234,204 votes in favor, 118 against, and no abstentions. This move will increase the authorized share capital to 1,000,000,000 shares at the new par value, aligning with the company's growth strategy.
外國私人發行人金醫療國際有限公司已向美國證券交易委員會（SEC）提交了2024年2月的報告。該報告詳細介紹了北京時間2024年1月30日（對應於美國東部時間2024年1月29日）舉行的股東特別大會（EGM）的議事情況。在股東特別大會期間，佔Jin Medical已發行普通股總額約79.65％的股東對一項提案進行了投票，該提案將每股現有普通股細分爲20股，實際上將每股面值從0.001美元降至0.00005美元。根據公司董事的決定，該細分將在2024年3月31日之前生效。該提案以6,234,204票贊成，118票反對，零票棄權獲得壓倒性通過。此舉將按新的面值將法定股本增加到1,000,000,000股，符合公司的增長戰略。
外國私人發行人金醫療國際有限公司已向美國證券交易委員會（SEC）提交了2024年2月的報告。該報告詳細介紹了北京時間2024年1月30日（對應於美國東部時間2024年1月29日）舉行的股東特別大會（EGM）的議事情況。在股東特別大會期間，佔Jin Medical已發行普通股總額約79.65％的股東對一項提案進行了投票，該提案將每股現有普通股細分爲20股，實際上將每股面值從0.001美元降至0.00005美元。根據公司董事的決定，該細分將在2024年3月31日之前生效。該提案以6,234,204票贊成，118票反對，零票棄權獲得壓倒性通過。此舉將按新的面值將法定股本增加到1,000,000,000股，符合公司的增長戰略。
有用
沒用